American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.

Ryan M. Daniel

Chief Patent Counsel
Fresenius Kabi USA, LLC

Stephanie Donahue

Principal Counsel – Global Patent
Litigation, Global IP Department
Legal, Ethics & Business Integrity
Sanofi-Aventis

Serena Farquharson-Torres

Executive Director, Assistant General Counsel
Innovation Law
Bristol Myers Squibb

Andrea Hutchison

Senior Associate General Counsel, IP Litigation
Gilead Sciences

Staci Julie

SVP and Chief IP Counsel
Teva Pharmaceuticals

James Kellerman

Senior Vice President, Intellectual Property
Astellas Pharma US, Inc.
James Leeds

James P. Leeds

Assistant General Patent Counsel
Eli Lilly & Company

Josephine Liu, Ph.D., J.D.

Vice President of IP, North America (ad interim)
Sandoz

Jeffrey N. Myers, Ph.D.

Vice President & Assistant General Counsel
Pfizer Inc

Pearl T. L. Siew

Senior Vice President and Head of IP
Design Therapeutics

Brian Stone

Vice President
Assistant Global General Counsel Regulatory
Mylan
Lars Taavola

Lars P. Taavola

VP, Chief IP Counsel & General
Counsel, Specialty Generics
Mallinckrodt Pharmaceuticals

Peter Waibel

Head, US Patent Litigation
Novartis Pharmaceuticals Corporation

Kevin Zive

Vice President, General Counsel, and Head of Global Intellectual Property
Apotex Inc.

Emeritus Members

Steve Auten

Stephen R. Auten

Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP
(Former Vice President, IP, Sandoz, Inc.)

Guy Donatiello

Senior Vice President, Intellectual Property
Endo Pharmaceuticals

George W. Johnston

Counsel
Gibbons P.C.
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)

David H. Silverstein, M.S., J.D.

Partner
Axinn, Veltrop & Harkrider LLP
(Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)

Meg Snowden

Shareholder
Margaret M. Snowden, P.C.
(Former Vice President,, Intellectual Property, Impax Laboratories)
Shashank Upadhye

Shashank Upadhye

Partner
Upadhye Tang LLP
(Former Vice President – Global Intellectual Property, Apotex, Inc.)